Pfizer R&D: If you can't do it, buy it
It looks like Pfizer is finally putting some much-needed money into research and development. Pfizer's not investing internally, of course; it's just buying another biotech firm in an attempt fill its dwindling pipelines. This time it's the privately held BioRexis Pharmaceutical Corpo